Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 3,602

Document Document Title
WO/2019/177436A1
The present invention relates to a modified polymerization initiator and a preparation method therefor. The modified polymerization initiator according to the present invention includes a unit derived from the compound represented by che...  
WO/2019/172150A1
Provided is a 2,3-bisphosphinopyrazine derivative represented by general formula (1). (In the formula: R1, R2, R3 and R4 represent an optionally-substituted linear or branched alkyl group having 1–10 carbon atoms, an optionally-substit...  
WO/2019/125323A3
The invention relates to an agent containing Cu(II) complexes of 2-hydroxy-5 metoxyacetophenone thiosemicarbazone and 4(N)-ethyl and n(4)-phenyl derivatives for supressing metastasis causing cancer death.  
WO/2019/150732A1
Silver oxalate characterized by having a 1% weight loss temperature of 190°C or higher in thermogravimetry. Silver oxalate characterized by having a maximum temperature of 219°C or higher in differential thermal analysis. The present i...  
WO/2019/146961A1
A composition for detecting an acidic compound, according to the present invention, is characterized in that the composition enables visual confirmation of detection of an acidic compound by using the characteristics of an organic metal ...  
WO/2019/134867A1
The invention concerns the use of a copper(ll) azide complex as a primary explosive, wherein the copper(ll) azide complex is of general formula Cua(N3)2a(L)x, wherein L is a ligand, a = 1 to 6 and x = 1 to 6.  
WO/2019/135565A1
Disclosed is a method for preparing a metal-organic framework (MOF)-containing matrix, comprising the steps of: 1) preparing a mixture solution by mixing an organic ligand precursor solution and a solution containing an anionic polymer; ...  
WO/2019/125323A2
The invention relates to an agent containing Cu(II) complexes of 2-hydroxy-5 metoxyacetophenone thiosemicarbazone and 4(N)-ethyl and n(4)-phenyl derivatives for supressing metastasis causing cancer death.  
WO/2019/123190A1
Provided is a light-emitting element having excellent reliability and a low drive voltage. This light-emitting element has an electron injection layer between a negative electrode and a light-emitting layer. The electron injection layer ...  
WO/2019/114609A1
The present invention discloses a novel metal organic complex and use thereof in an organic electronic component, particularly a phosphorescent organic light emitting diode. The present invention also relates to an organic electronic com...  
WO/2019/115470A1
The invention concerns a method for preparing a modified polymer comprising: - a step of anionic polymerisation of at least one diene monomer in the presence of a difunctional polymerisation initiator, in order to obtain a difunctional l...  
WO/2019/116007A1
A process for the preparation of a shaped MOF, the process comprising: providing a first reactant comprising at least one metal in ionic form and a second reactant comprising at least one organic ligand capable of associating with said m...  
WO/2019/112383A1
The present invention relates to a metal mineral diaminate and a novel preparation method therefor and, specifically, to a method for preparing a metal mineral diaminate causing no byproduct by allowing a metal mineral source to react wi...  
WO/2019/096209A1
Provided are a chiral 1,3-diarylimidazolium salt carbene precursor (S), a synthesis method therefor, a metal salt compound, and an application thereof. The chiral 1,3-diarylimidazolium salt carbene precursor catalyzes a reaction between ...  
WO/2019/092721A1
Complexes comprising a coordinated Cu(II) ion are described herein, which are capable of binding to an extracellular portion of Ctr1 such that the complex with the Cu(II) ion is transported through the Ctr1. The complexes may comprise a ...  
WO/2019/091534A1
There is provided two angiogenesis clinical PET tracers, namely 68Ga-NODAGA- E[c(RGDyK)]2 and 64Cu-NODAGA-E[c(RGDyK)]2 for imaging of neo-angiogenesis in humans.  
WO/2019/086614A1
The present invention is directed to novel compounds of Formula (I): pharmaceutically acceptable salts or solvates thereof, and their use, in particular in the treatment or prevention of malaria.  
WO/2019/083203A1
The present invention relates to a method for preparing a modified polymerization initiator, capable of preparing a modified polymerization initiator with a high conversion rate by minimizing side reactions. Therefore, the method for pre...  
WO/2019/078715A1
The present invention relates to a compound of the formula (l): [Z-L]MQn (l) wherein Z represents a metal cation selected from the group consisting of palladium, platinum or gold or mixtures thereof; L is a tetradentate polypyridyl ligan...  
WO/2019/070337A1
A system and method for delivering silver ion biocide is described herein. The systems described relate to passing water from a water system through a silver ion release module and optional high-concentration silver ion release module. T...  
WO/2019/069828A1
Provided is an optically active 2,3-bisphosphinopyrazine derivative represented by general formula (1). (In the formula, R1 denotes a group selected from among a branched alkyl group having 3 or more carbon atoms, an adamantyl group, an ...  
WO/2019/067635A1
The disclosure provides methods for sequencing nucleic acids using, including with nucleotide analogs and subsequently appended labels.  
WO/2019/057050A1
The present invention relates to the technical field of porous composite material preparation, and provides a slurry synthesis method for a porous composite framework material. A mass ratio of a solvent to a solid reactant is controlled,...  
WO/2019/049775A1
Disclosed is a lithium boron sulfate compound represented by formula (I). In formula (I), R0 represents a C1–20 alkoxy group, or a group represented by formula (II). In formula (II), * indicates a bond position.  
WO/2019/044478A1
The invention is an electroconductive substance comprising a complex containing a rubeanic acid ligand and a copper ion. The copper ion included in the complex comprises a copper (I) ion. In addition, this electroconductive substance is ...  
WO/2019/046761A1
Disclosed herein are compound embodiments that are useful for treating a variety of diseases, particularly neurological diseases, motor neuron diseases, copper deficiency-related diseases, and/or mitochondrial deficiencies. The compound ...  
WO/2019/031232A1
A production method for a 2,3-bisphosphinopyrazine derivative, characterized by including a first step, in which a base is added to and reacted with a liquid containing a 2,3-dihalogenopyrazine represented by general formula (1), a hydro...  
WO/2019/030304A1
The invention relates to ylide-functionalised phosphane ligands, the production of same and use in transition metal compounds, as well as the use of same as catalysts in organic reactions.  
WO/2019/024707A1
Metal nanoparticles are directly synthesized on polymers comprising a plurality of thiol groups to form compositions useful as electron microscopy tags.  
WO/2019/021144A1
A process of hydrogel preparation by gelation of water with only one amino acid, which is Lhistidine, where during gelation for 15 hours, multiple thread-like nano fibers of n- number of metal-organic co-ordinated polymers come together ...  
WO/2019/021143A1
An anti-microbial hydrogel comprising n-number of metal organic coordinated compound with one silver ion sandwiched between two L-histidine molecules, arranged in a particular manner, with π-π stacking in the upper and the lower side w...  
WO/2019/012918A1
The method according to the present invention for producing an optically active 2,3-bisphosphinopyrazine derivative comprises: a step for preparing solution A which contains a 2,3-dihalogenopyrazine represented by general formula (1) and...  
WO/2019/005876A1
Disclosed herein are gold compounds and methods of use thereof as antibacterials. Specifically exemplified are methods of treating a Mycobacterium infection by administering therapeutically effective amounts of the gold compounds.  
WO/2019/006327A1
The present disclosure relates gold carbene naphthoquinone compounds and salts thereof. In some aspects, these compounds can be used to treat cancer including cancers which are resistant to one or more other chemotherapeutic agents such ...  
WO/2018/236199A1
The present invention relates to a ligand for forming a copper complex, a ligand for forming a palladium complex, a copper complex catalyst, a palladium complex catalyst, a production method therefor and a use thereof.  
WO/2018/223180A1
The present invention relates to compounds that are useful as radiopharmaceuticals and radioimaging agents which bear a radionuclide-chelating agent. These coordinated compounds are useful in radiotherapy and diagnostic imaging. The inve...  
WO/2017/205092A8
Highly thermal and photo-stable inorganic-organic hybrid phosphor compounds, in which a copper (I) halide module is coordinated with a multi-dentate organic ligand. Also disclosed are semiconductor and light emitting devices comprising t...  
WO/2018/217637A1
Au(III) complexes for [18F] trifluoromethylation and methods for producing the same are disclosed. A gold complex comprises Au(CF3)2LR, wherein L comprises a solubility supporting ligand and R comprises an organic substituent. The Au(III...  
WO/2018/212356A1
Stable perovskite films having substantially-no phase transition within a predetermined temperature range are disclosed. In the films, formation of carrier traps is suppressed. Thermally stable perovskite solar cells and light-emitting d...  
WO/2018/206595A1
The invention relates to novel cuprate compounds which are suitable as luminous substances in an organic light emitting diode (OLED). The invention further relates to methods for producing said novel cuprate compounds, and to organic lig...  
WO/2018/204461A1
Inorganic-organic hybrid structures having both ionic and coordinate bonds in a molecular cluster possessing the features of structural diversity, high luminescence and stability, and excellent dispersibility, suitable for use as lightin...  
WO/2018/192686A1
The invention relates to a method for producing, amongst other things, amino-acid and/or hydroxycarboxylic-acid metal chelates, a solvent-free mixture of at least one metal oxide, metal hydroxide, metal carbonate or oxalate, and the soli...  
WO/2018/186490A1
Provided are a novel naphthalocyanine compound having strong absorption in the near infrared region, very little absorption in the visible light region, high fastness such as light resistance and heat resistance, and good solubility in o...  
WO/2018/159505A1
Provided are: a dissimilar-metal salt assembly which is a dendrimer capable of having a large number of, i.e., four or more types, particularly five or more types of dissimilar-metal salt compounds having dissimilar metals precisely inte...  
WO/2018/153330A1
Disclosed in the present invention are a biflavonoid-copper complex, a preparation method and an application thereof. In the present invention, amentoflavone is used as a ligand and a copper ion is used as a central ion, an amentoflavone...  
WO/2018/101663A3
The present invention relates to a composition for biotissue clearing, and a biotissue clearing method using the same.  
WO/2018/144101A1
Described herein are labeling agents, specifically [11C]fluoroform, [11C]difluoromethane, [11C]fluoromethyl iodide, [11C]fluoromethyl bromide, [11C]fluoromethyl chloride, [11C]fluoromethyl trifluoromethansulfonate, [11C]difluoromethyl io...  
WO/2018/139470A1
There is a desire for a technique wherein a sodium 2,2,6,6-tetramethylpiperidide (Na-TMP) compound can be economically and efficiently synthesized in a short time under mild conditions by a simple procedure including a small number of st...  
WO/2018/140235A1
Vapor deposition processes for forming thin films comprising gold on a substrate in a reaction space are provided. The processes can be cyclical vapor deposition processes, such as atomic layer deposition (ALD) processes. The processes c...  
WO/2018/113782A1
Disclosed is a metal-organic complex of the general formula M(L)n(L1)m(1), wherein M(L)n is selected from one of the general formulas (2) and (3), and M is a metal atom; L is a monoanionic monodenate chelate ligand; L1 is another ligand;...  

Matches 1 - 50 out of 3,602